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Available online 15 October 2016Objective: Papillary squamous cell carcinomaof the cervix (PSCC) is a rare and distinct form of cervical carcinoma.
Detecting stromal invasion on biopsy is difﬁcult due to the papillary growth of the tumor. Here we present two
cases that highlight the diagnostic and clinical challenges of PSCC.
Case 1: A 50-year-old woman found to have carcinoma on a routine pap-smear. The patient was diagnosed with
PSCC on colposcopic biopsy and underwent a radical hysterectomy, bilateral salpingo-oophorectomy and pelvic
lymph node dissection. Her ﬁnal pathology demonstrated PSCC with no evidence of stromal invasion. At her 3-
month follow up visit, she was noted to have a tumor recurrence at the vaginal cuff, again with no stromal inva-
sion. She is currently undergoing deﬁnitive radiation therapy with sensitizing cisplatin.
Case 2: An 82-year-old woman presented with post-menopausal bleeding and was found to have an exophytic
mass. Biopsies were taken and showed PSCC with no stromal invasion identiﬁed. She underwent a total laparo-
scopic hysterectomyandbilateral salpingo-oophorectomy. Final pathology indicated no invasion. She is currently
being followed for persistent vaginal dysplasia.
Conclusion: PSCC is a rare tumor that has previously beendescribed as less aggressive than classical squamous cell
carcinoma. These two cases demonstrate the complex behavior of the disease. Case 1 highlights that PSCC may
recur even when stromal invasion cannot be conﬁrmed pathologically.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Papillary squamous cell carcinoma of the cervix (PSCC) is a rare sub-
type of squamous cell carcinoma of the cervix. It has been reported to
represent 1.6% of all cervical cancers (Randall et al., 1986). Due to its rar-
ity, very little is known about the clinical behavior of the disease. PSCC
grows superﬁcially in an exophyticmanner similar to other papillary le-
sions of the cervix. However, PSCC is histologically unique and clinically
more aggressive and therefore should be distinguished from verrucous
and condylomatous carcinoma (Randall et al., 1986; Koenig et al., 1997).
It has also been reported that PSCC may differ from traditional squa-
mous cell carcinoma in that it has a tendency for late metastasis and re-
currence (Randall et al., 1986; Koenig et al., 1997). The papillary growth
and histology make it difﬁcult to diagnose invasion on routine biopsiesy have no conﬂicts of interest to
ology, Department of Obstetrics
ge of Medicine, Jacobi Medical
wy S, Bronx, NY 10461, United
. This is an open access article under(Randall et al., 1986; Koenig et al., 1997; Nagura et al., 2014;
Mirhashemi et al., 2003). We present two cases of PSCC in situ.
2. Case 1
A 50-year-old Guianese, gravida 2 with no signiﬁcant past medical
history was referred to our clinic for evaluation of squamous cell carci-
noma incidentally identiﬁed on pap smear. Her pap smear also returned
positive for high risk human papilloma virus (HPV). The patient denied
any abnormal bleeding, discharge or abdominal pain. Her last pap smear
in 2008 was normal. On exam she was found to have a 2.5 cm cervical
lesion at 3 o'clock that was “bulging” and noted to be exophytic in na-
ture. Biopsy of the lesion was performed which showed fragments of
carcinoma with a papillary pattern showing full thickness atypia and
mitotic activity, representing at least carcinoma in situ without obvious
stromal invasion. Based on her initial biopsy anddue to themorphologic
resemblance to a transitional cell neoplasm, PSCC could not be ex-
cluded, as seen in Figs. 1 and 2.
Computerized tomography (CT) scan of the chest, abdomen and
pelvis was performed and showed no signs of extra-cervical disease.
The patient was diagnosed with clinical FIGO stage IB1 cervical
squamous cell carcinoma and subsequently underwent an exploratorythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Papillary squamous cell carcinoma composed of ﬁbrovascular cores with
multilayered epithelium (H&E stain, 10×).
Fig. 3. In this variant of squamous cell carcinoma, the cells can exhibit eosinophilic
cytoplasm and full thickness hyperchromasia. No invasion was identiﬁed in this
specimen (H&E stain, 40×).
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pelvic lymph node dissection. Her ﬁnal pathology results showed squa-
mous cell carcinoma-in-situ, both conventional and papillary type con-
ﬁned to the cervix with no evidence of nodal disease. All margins were
negative for invasive disease or high grade lesions. The cervical margin
was positive at 3 to 9 o'clock for a low-grade intraepithelial lesion. No
stromal invasion was identiﬁed despite thorough sampling of the
cervix.
The patientwas seen for 3-month follow up andwas noted to have a
1 cm lesion at the vaginal cuff. A biopsy showed recurrent PSCCwithout
stromal invasion. She is currently undergoing radiation therapy with
cisplatin chemo-sensitization.3. Case 2
An 82-year-old Ghanaianwoman, gravida 4, with a history of hyper-
tension, presented to our clinic for evaluation of post-menopausal
bleeding. On exam she was found to have a 4–5 cm exophytic mass oc-
cupying and completely replacing the cervix.
Biopsies were performed showing dysplastic squamous mucosa
with full-thickness cytologic atypia in a papillary conﬁguration with
abundantmitoses (Fig. 3). These biopsies showed high risk HPV expres-
sion. The base of the lesion was not identiﬁed however no deﬁnitive
stromal invasionwas seen on deeper sections. It was felt that this lesion
might represent a superﬁcial component of squamous cell carcinomaFig. 2. The appearance of the tumor varies from squamous to squamotransitional. The
mitoses are present throughout the epithelium (black arrows) (H&E stain, 40×).variant such as PSCC given the arrangement and appearance of the
cells lining the ﬁbrovascular cores (Fig. 4).
The patient underwent a CT scan that showed an exophytic mass
measuring 4.2 × 3.6 cm along the left body of the uterus. There was
no evidence of extra-cervical disease. She subsequently underwent clin-
ical stagingwith examination under anesthesia, sigmoidoscopy and cys-
toscopy and was found to have 4–5 cmmass at the apex of the vagina.
The majority of the exophytic mass was excised on endocervical curet-
tage, and the remaining cervix retracted and was ﬂush with the vagina.
Therewas no involvement of the urinary bladder or rectum. The pathol-
ogy again returned as dysplastic squamous mucosa with full-thickness
cytologic atypia in a papillary conﬁguration with no stromal invasion.
She subsequently had a positron emission tomography (PET) scan
which showed focal activity in the cervix (SUV 3.9). Given that invasion
could not be conﬁrmed and that the cervix now appeared normal on ex-
amination with no concern for parametrial invasion, the decision was
made to proceed with a simple total laparoscopic hysterectomy and bi-
lateral salpingo-oophorectomy. Final pathology showed a high grade
squamous intraepithelial lesion and histologic papillary features with-
out invasive carcinoma. All surgical margins were clear of cancer and
dysplasia. The patient has been followed in clinic and 6 months follow-
ing hysterectomy has recurrent low-grade dysplasia at the apex of the
vaginal cuff.Fig. 4. PSCC showing a hyalinized ﬁbrovascular core. The cores are usually slender, such as
the one below (blue arrow) (H&E stain, 20×).
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Papillary cervical lesions were ﬁrst described in 1952 by Marsh: 31
cases were reported, three of which were malignant (Marsh, 1952). In
1986, Randall et al. presented 9 cases of papillary squamous carcinoma
of the cervix and deﬁned pathologic criteria for diagnosis: full-thickness
dysplastic cells in a papillary architecture with ﬁbrovascular cores and
the invasive component that is usually deep to the papillary excres-
cences (Randall et al., 1986). From this deﬁnition, Koenig further differ-
entiated PSCC into three groups: predominantly squamous cell,
predominantly transitional cell, andmixed. In this review of 32 patients,
the majority of the patients were found to have a mixed histology
(Koenig et al., 1997). In 2014, Nagura et al. evaluated 28 cases of PSCC
on superﬁcial biopsy and found that only 12 were predominantly
PSCC on ﬁnal diagnosis (Nagura et al., 2014).
Original data suggested that PSCC behaves clinically similar to tradi-
tional squamous cell carcinoma (Randall et al., 1986; Koenig et al.,
1997). Recently, the disease has been suggested to be less aggressive
than typical squamous cell carcinoma (Nagura et al., 2014;
Mirhashemi et al., 2003). It is further distinguishable from typical squa-
mous cell carcinoma in that it has a tendency for later recurrence;
Koenig reported an isolated recurrence 12 years later (Koenig et al.,
1997). In a retrospective study of 12 patients with PSCC, the rate of
high risk HPV expression in PSCC was found to be signiﬁcantly less
than that of squamous cell carcinoma (50% vs. 90%) (Mirhashemi et
al., 2003). Therefore, theremay be a differentmechanism of carcinogen-
esis. In that same study, the patients with HPV expression were more
likely to present at an advanced stage. Further, the two patients with re-
currence both had high risk HPV expression (Mirhashemi et al., 2003).
More recent case reports have detected HPV expression in PSCC (Tang
et al., 2013; Sawada et al., 2010; Eleuterio et al., 2009; Brinck et al.,
2000). One case report notes no evidence of recurrence after 10months
(Sawada et al., 2010). The other case reports do not remark on recur-
rence or risk of recurrence. Our cases both have HPV expression consis-
tent with the recent case reports. The pathologic signiﬁcance of HPV
expression and development of PSCC is an area that deserves further ex-
ploration. Furthermore, the HPV testing and detection rates have in-
creased signiﬁcantly in the last 10 years and may contribute to the
increasing HPV association in these speciﬁc tumors.
The National Comprehensive Cancer Network (NCCN) treatment
guidelines for cervical cancer do not speciﬁcally address PSCC (Koh et
al., 2015). However experts suggest treatment of PSCC should follow
the same treatment guidelines as squamous cell carcinoma of the cervix
(Randall et al., 1986; Koenig et al., 1997; Nagura et al., 2014). PSCC
grows in an exophytic fashionmaking the diagnosis of stromal invasion
on routine biopsies difﬁcult; invasion is only diagnosed in 50–60% of
cases with superﬁcial biopsies (Koenig et al., 1997; Nagura et al.,
2014). Themajority of PSCC cases are found to have invasion onﬁnal pa-
thology (Randall et al., 1986; Koenig et al., 1997; Mirhashemi et al.,
2003). PSCC is often confused with squamous cell carcinoma in situ. In-
vasion can appear as nests at the base of the lesion, and in some cases
the actual papillae may invade. The diagnosis is even more difﬁcult be-
cause biopsies may have superﬁcial papillary features, but are found to
be conventional squamous cell carcinoma on ﬁnal pathology (Nagura
et al., 2014). Our cases conﬁrm the difﬁculty of diagnosing invasive can-
cer on initial biopsies and ﬁnal deﬁnitive treatment.
Given that invasion is difﬁcult to diagnose on biopsy, Nagura et al.,
performed magnetic resonance imaging to evaluate for stromal inva-
sion. Ifmagnetic resonance imaging showed less than 3mmof invasion,
a simple hysterectomy or cervical conizationwas performed. This study
showed that invasion could accurately be diagnosed on MRI and re-
ported no recurrence 49 months after hysterectomy or cervical
conization (Nagura et al., 2014). This study suggests that PSCC may be
amenable to treatment with less invasive procedures and that PSCC
may beneﬁt from a different work-up and treatment pathway than typ-
ical squamous cell carcinoma (Nagura et al., 2014).Both cases showed no invasion on biopsy, consistent with previous
reports (Randall et al., 1986; Koenig et al., 1997; Nagura et al., 2014).
In the ﬁrst case, stromal invasion was highly suspected after superﬁcial
biopsies were taken. Because of this high suspicion of invasive disease, a
radical hysterectomy was performed. In the second case, multiple deep
biopsies were performed before proceeding to hysterectomy. These bi-
opsies conﬁrmed no stromal invasion. Given low suspicion for invasion
and shrinking of the cervix, an extrafascial hysterectomy was per-
formed. Both of our patients had no stromal invasion on ﬁnal pathology.
Pathologic consultation was obtained in both cases with agreement of
no stromal invasion. Our ﬁrst patient now has recurrence of disease
three months after a radical hysterectomy. To our knowledge, this is
the ﬁrst reported case of recurrence without any invasion diagnosed
on pathology. The second patient has persistent local dysplasia. Given
these ﬁndings, PSCC lesions without stromal invasion should be treated
clinically as cancer according to the corresponding clinical stage. These
ﬁndings emphasize the clinically challenging nature of the disease. In
our second case, cone biopsy was considered; however, once the
tumor was extensively biopsied, the cervix was ﬂush with vagina
and cone biopsy was considered unsafe. MRI could have been poten-
tially used in this case to estimate invasion before undergoing her
procedure.
In conclusion, PSCC is a rare variant of squamous cell carcinoma of
the cervix and it is important to recognize it as a distinct clinical entity
pre-operatively. Given the indeterminate nature of the disease and dif-
ﬁcultly diagnosing stromal invasion, conization or imaging with MRI
should be performed to assess for invasion prior to proceedingwith de-
ﬁnitive surgery. Furthermore, a pathology consultation may be helpful
in providing agreement regarding stromal invasion and further man-
agement. In our cases, pathology, radiation oncology, as well as gyneco-
logic oncologists were instrumental in diagnosis and treatment of the
patients. A multi-disciplinary approach should be considered in the
treatment of patients with PSCC.
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